title: Executive summary: management of the critically ill patient with severe acute pancreatitis.
authors.affiliation: American Thoracic Society
authors.forename: Avery B
authors.initials: AB
authors.lastname: Nathens
authors.forename: J Randall
authors.initials: JR
authors.lastname: Curtis
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Beale
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: Cook
authors.forename: Rui P
authors.initials: RP
authors.lastname: Moreno
authors.forename: Jacques-Andre
authors.initials: JA
authors.lastname: Romand
authors.forename: Shawn J
authors.initials: SJ
authors.lastname: Skerrett
authors.forename: Renee D
authors.initials: RD
authors.lastname: Stapleton
authors.forename: Lorraine B
authors.initials: LB
authors.lastname: Ware
authors.forename: Carl S
authors.initials: CS
authors.lastname: Waldmann
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003422:Critical Care / Q000592:standards* / Q000639:trends; D016638:Critical Illness; D006801:Humans; D007362:Intensive Care Units; D007813:Laparotomy / Q000379:methods; D018529:Nutritional Support; D010195:Pancreatitis / Q000175:diagnosis* / Q000628:therapy*; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents